New scan could reveal hidden kidney cancer activity
NCT ID NCT04989959
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether a special PET/CT scan using a tracer called [18F]PT2385 can detect a protein (HIF2α) that helps kidney cancers grow. About 35 adults with kidney cancer or a genetic condition called VHL syndrome will receive the scan, and results will be compared with tissue samples. The goal is to improve how doctors see and understand kidney cancer, not to treat it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do Younger-Age pancreatic tumors behave differently? a new study digs in
- Can we predict who needs extra therapy after kidney cancer surgery?
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Can a Two-Pronged immune attack shrink kidney tumors before surgery?
- Can a Two-Drug combo outsmart advanced cancers?
- Can a rapid drug switch outsmart advanced kidney cancer?